OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Design, synthesis and biological evaluation of 2-((4-sulfamoylphenyl)amino)-pyrrolo[2,3-d]pyrimidine derivatives as CDK inhibitors
Bo Yang, Yanni Quan, Wuli Zhao, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 8
Bo Yang, Yanni Quan, Wuli Zhao, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 8
Showing 8 citing articles:
Recent Discovery and Development of Inhibitors that Target CDK9 and Their Therapeutic Indications
Yuming Zhang, Lianhai Shan, Wentao Tang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 7, pp. 5185-5215
Closed Access | Times Cited: 10
Yuming Zhang, Lianhai Shan, Wentao Tang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 7, pp. 5185-5215
Closed Access | Times Cited: 10
The anticancer therapeutic potential of pyrimidine–sulfonamide hybrids
Peng Zhang, Congcong Shi, Tongbao Dong, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 9, pp. 905-924
Closed Access | Times Cited: 2
Peng Zhang, Congcong Shi, Tongbao Dong, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 9, pp. 905-924
Closed Access | Times Cited: 2
Novel pyrimidine Schiff bases and their selenium-containing nanoparticles as dual inhibitors of CDK1 and tubulin polymerase: design, synthesis, anti-proliferative evaluation, and molecular modelling
Samar El‐Kalyoubi, Samiha A. El‐Sebaey, Ahmed A. El‐Sayed, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 5
Samar El‐Kalyoubi, Samiha A. El‐Sebaey, Ahmed A. El‐Sayed, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 5
Pyrrolo[2,3-d]pyrimidines as potential kinase inhibitors in cancer drug discovery: A critical review
Malyala Sai Madhurya, Vanashree Thakur, Sowmya Dastari, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107867-107867
Closed Access | Times Cited: 1
Malyala Sai Madhurya, Vanashree Thakur, Sowmya Dastari, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107867-107867
Closed Access | Times Cited: 1
A novel strategy to bind pyrimidine sulfonamide derivatives with odd even chains: exploration of their design, synthesis and biological activity evaluation
Meng Zhou, Ying Liu, Shuo Wang, et al.
Molecular Diversity (2023)
Closed Access | Times Cited: 3
Meng Zhou, Ying Liu, Shuo Wang, et al.
Molecular Diversity (2023)
Closed Access | Times Cited: 3
Current scenario of fused pyrimidines with in vivo anticancer therapeutic potential
Zhi Xu, Li Wang, Hongyan Hu
Archiv der Pharmazie (2024)
Closed Access
Zhi Xu, Li Wang, Hongyan Hu
Archiv der Pharmazie (2024)
Closed Access
A Concise Review on Microwave Assisted Synthetic Approches of Sulfonamides
Lakshman R. Meena, Jigar Y. Soni, Satyanarayana Battula
ChemistrySelect (2024) Vol. 9, Iss. 37
Closed Access
Lakshman R. Meena, Jigar Y. Soni, Satyanarayana Battula
ChemistrySelect (2024) Vol. 9, Iss. 37
Closed Access
Current Developments of Pyrrolo[2,3-d]pyrimidines with Anticancer Potential (A Review)
Zhen Tan, Jie Deng, Qianwei Ye, et al.
Russian Journal of General Chemistry (2023) Vol. 93, Iss. 10, pp. 2645-2662
Closed Access | Times Cited: 1
Zhen Tan, Jie Deng, Qianwei Ye, et al.
Russian Journal of General Chemistry (2023) Vol. 93, Iss. 10, pp. 2645-2662
Closed Access | Times Cited: 1
